Genomic medicine is failing most of humanity
Most genomic advances benefit people of European ancestry, limiting precision medicine's reach globally and highlighting the urgent need for African-led genome research initiatives.
This Nature Reviews Nephrology commentary argues that genomic medicine systematically fails non-European populations due to underrepresentation in large-scale genomic studies, with African genomes particularly absent, limiting polygenic risk scores and precision oncology applications globally. The authors call for systemic investment in Africa-centered genomic initiatives to ensure equitable benefit.
What the study was
- Study design
- Commentary/Opinion
- Population
- Global genomics research populations
- Category
- Public Health
- Maturity
- Exploratory
- Journal
- Nature Reviews Nephrology
Why it surfaced
High-profile Nature Reviews commentary on equity in genomics; relevant to precision medicine watchlist; opinion piece limits evidence grade.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.